https://www.selleckchem.com/pr....oducts/vacuolin-1.ht
0-5.8)], higher liver stiffness measurement (≥14.6kPa) [HR 4.2, 95%CI (2.3-7.6)], diabetes mellitus [HR 4.2, 95%CI (2.4-7.4)] at pre-treatment were associated with HCC occurrence. HCC patients in the DAAs induced SVR group had a higher prevalence of NAFLD as compared with those in the PR induced SVR group, 62% (18/29) vs 28% (7/25), p=0.026. A nomogram formulated with the above six independent variables had a Concordance-Index of 0.835 (95% CI 0.783-0.866). Underlying NAFLD is associated with increased incidence of HCC in chronic HCV